Juvenescence

Morphoceuticals raises $8m to advance electroceutical approach to regenerative medicine

Biotech Investment

Juvenescence appoints Dr Richard Marshall CBE as CEO

Investment

Jim Mellon: Longevity could be the best investment you ever make

Investment

Juvenescence invest in Chrysea’s mystery ingredient for cellular regeneration

Investment

Juvenescence and Buck Institute launch company to target heart disease

Biotech Investment

Juvenescence and Buck Institute set the (ke)tone for metabolism and ketosis research

Biotech

Active ingredient in Juvenescence’s Metabolic Switch induces ketosis, new study finds

Biotech

Juvenescence targets fibrotic disease with new investment

Investment

From biotech to inflection points with James Peyer and Greg Bailey

Investment Videos